SOAT1 and rheumatoid arthritis: Although JAKi function effectively in RA patients, they are expensive for broader application and demonstrate adverse effects, including hepatotoxicity, gastrointestinal perforations, thromboembolism, herpes zoster, and tuberculosis; therefore, some studies are focusing on exploring natural compounds that can inhibit JAK/STAT signaling (87) (Table 2).